Press Releases
Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers
Debiopharm joins discussions with international health organisations to fight anti-microbial resistance at the 2023 World AMR Congress
Debiopharm Launches “Oncolifestyle” website in Switzerland for People Living with Cancer
8e Challenge Qualité de vie du patient : cinq finalistes reçoivent 5000 francs chacun et avancent en finale
Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical…
Debiopharm Shares Oncology Program Updates at ASCO 2023 for Novel WEE1 Inhibitor, and First-In-Class CA IX Theranostic Approach
Debiopharm Launches Phase 1 Research in Small Cell Lung Cancer with WEE1 inhibitor Debio 0123 to Outsmart DDR
Debiopharm Launches Phase 1/2 Combination Trial Investigating Brain-Penetrant Selective WEE1 Inhibitor for Brain Cancer Patients